Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by West Oak Capital LLC

West Oak Capital LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 182.7% in the fourth quarter, Holdings Channel reports. The firm owned 2,205 shares of the company’s stock after acquiring an additional 1,425 shares during the period. West Oak Capital LLC’s holdings in Cardinal Health were worth $233,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp grew its position in shares of Cardinal Health by 2.1% during the first quarter. State Street Corp now owns 21,802,799 shares of the company’s stock worth $1,246,751,000 after acquiring an additional 457,777 shares during the last quarter. Invesco Ltd. grew its position in Cardinal Health by 9.0% during the 1st quarter. Invesco Ltd. now owns 6,186,052 shares of the company’s stock worth $350,748,000 after purchasing an additional 511,826 shares during the last quarter. Geode Capital Management LLC increased its stake in Cardinal Health by 0.5% in the first quarter. Geode Capital Management LLC now owns 5,396,988 shares of the company’s stock valued at $406,560,000 after purchasing an additional 28,250 shares during the period. Morgan Stanley increased its position in Cardinal Health by 3.6% in the 4th quarter. Morgan Stanley now owns 4,594,184 shares of the company’s stock valued at $353,155,000 after acquiring an additional 161,667 shares during the period. Finally, Ameriprise Financial Inc. raised its stake in shares of Cardinal Health by 82.2% during the third quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock worth $358,390,000 after purchasing an additional 1,862,291 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Cardinal Health stock traded down $0.11 during mid-day trading on Thursday, hitting $111.93. 295,181 shares of the company were exchanged, compared to its average volume of 2,389,891. Cardinal Health, Inc. has a 12-month low of $72.52 and a 12-month high of $116.04. The company has a market capitalization of $27.22 billion, a P/E ratio of 43.91, a PEG ratio of 1.08 and a beta of 0.68. The business’s 50 day simple moving average is $108.39 and its two-hundred day simple moving average is $101.85.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. During the same quarter last year, the company earned $1.32 earnings per share. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. Equities research analysts predict that Cardinal Health, Inc. will post 7.29 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Monday, April 1st will be given a $0.5006 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date is Thursday, March 28th. Cardinal Health’s dividend payout ratio is presently 78.74%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on CAH shares. SVB Leerink initiated coverage on shares of Cardinal Health in a research note on Monday, February 26th. They set an “outperform” rating and a $125.00 price target on the stock. Leerink Partnrs reissued an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. Barclays initiated coverage on Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Argus upgraded Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. Finally, Wells Fargo & Company assumed coverage on shares of Cardinal Health in a research report on Thursday, December 14th. They set an “underweight” rating and a $96.00 target price on the stock. One investment analyst has rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $103.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.